Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts

被引:263
作者
Stone, GW
Rogers, C
Hermiller, J
Feldman, R
Hall, P
Haber, R
Masud, A
Cambier, P
Caputo, RP
Turco, M
Kovach, R
Brodie, B
Kuntz, RE
Popma, JJ
Ramee, S
Cox, DA
机构
[1] Cardiovasc Res Fdn, New York, NY 10022 USA
[2] Lenox Hill Heart & Vasc Inst, New York, NY USA
关键词
grafting; stent; complications;
D O I
10.1161/01.CIR.0000080894.51311.0A
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The high rate of periprocedural complications resulting from atherothrombotic embolization after percutaneous intervention in diseased saphenous vein grafts is reduced by distal microcirculatory protection using a balloon occlusion and aspiration system. Whether filter-based catheters, which offer the inherent advantages of maintained perfusion and ease of use, are as effective for this purpose has not been established. Methods and Results-A total of 651 patients undergoing percutaneous intervention of 682 saphenous vein graft lesions were prospectively randomized to distal protection with the filter-based FilterWire EX versus the GuardWire balloon occlusion and aspiration system. Device success was 95.5% and 97.2% with the FilterWire EX and GuardWire, respectively (P = 0.25). Postprocedural measures of epicardial flow and angiographic complications were similar between the 2 groups, although bailout IIb/IIIa inhibitors were required slightly less frequently in the FilterWire EX group (0% versus 1.5%, P = 0.03). The primary end point, the composite incidence of death, myocardial infarction, or target vessel revascularization at 30 days, occurred in 9.9% of FilterWire EX patients and 11.6% of GuardWire patients ( difference [95% CI]= -1.7% [-6.4%, 3.1%]; P for superiority=0.53, P for noninferiority=0.0008). Conclusions-Distal protection with the FilterWire EX may be safely used as an adjunct to percutaneous intervention of diseased saphenous vein grafts and, compared with distal protection with the GuardWire balloon occlusion and aspiration system, results in similar rates of major adverse cardiac events at 30 days.
引用
收藏
页码:548 / 553
页数:6
相关论文
共 13 条
  • [1] Effect of the distal-balloon protection system on microembolization during carotid stenting
    Al-Mubarak, N
    Roubin, GS
    Vitek, JJ
    Iyer, SS
    New, G
    Leon, MB
    [J]. CIRCULATION, 2001, 104 (17) : 1999 - 2002
  • [2] PROVING THE NULL HYPOTHESIS IN CLINICAL-TRIALS
    BLACKWELDER, WC
    [J]. CONTROLLED CLINICAL TRIALS, 1982, 3 (04): : 345 - 353
  • [3] BALLOON ANGIOPLASTY FOR THE TREATMENT OF LESIONS IN SAPHENOUS-VEIN BYPASS GRAFTS
    DEFEYTER, PIMJ
    VANSUYLEN, RJ
    DEJAEGERE, PPT
    TOPOL, EJ
    SERRUYS, PW
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (07) : 1539 - 1549
  • [4] Initial multicenter experience with a novel distal protection filter during carotid artery stent implantation
    Grube, E
    Colombo, A
    Hauptmann, E
    Londero, H
    Reifart, N
    Gerckens, U
    Stone, GW
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 58 (02) : 139 - 146
  • [5] Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts
    Grube, E
    Schofer, J
    Webb, J
    Schuler, G
    Colombo, A
    Sievert, H
    Gerckens, U
    Stone, GW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (08) : 941 - 945
  • [6] Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection
    Grube, E
    Gerckens, U
    Yeung, AC
    Rowold, S
    Kirchhof, N
    Sedgewick, J
    Yadav, JS
    Stertzer, S
    [J]. CIRCULATION, 2001, 104 (20) : 2436 - 2441
  • [7] A MULTICENTER, RANDOMIZED TRIAL OF CORONARY ANGIOPLASTY VERSUS DIRECTIONAL ATHERECTOMY FOR PATIENTS WITH SAPHENOUS-VEIN BYPASS GRAFT LESIONS
    HOLMES, DR
    TOPOL, EJ
    CALIFF, RM
    BERDAN, LG
    LEYA, F
    BERGER, PB
    WHITLOW, PL
    SAFIAN, RD
    ADELMAN, AG
    KELLETT, MA
    TALLEY, JD
    SHANI, J
    GOTTLIEB, RS
    PINKERTON, CA
    LEE, KL
    KEELER, GP
    ELLIS, SG
    FRANCO, I
    DEBOWEY, D
    LINCOFF, M
    KEREIAKES, D
    ABBOTTSMITH, C
    KENT, K
    LEON, M
    PICHARD, A
    SATLER, L
    POPMA, J
    HINOHARA, T
    KOSINSKI, E
    SIMONTON, C
    BERSIN, RM
    CEDARHOLM, J
    WILSON, B
    MCKEEVER, LS
    MARTIN, F
    CHAPEKIS, A
    GEORGE, BS
    COWLEY, M
    PINKERTON, C
    PETERS, T
    COHEN, M
    JACOBS, A
    FAXON, DP
    LEVINE, G
    KELLETT, M
    KING, S
    MASDEN, R
    MOONEY, M
    WHITE, CJ
    HOFLING, B
    [J]. CIRCULATION, 1995, 91 (07) : 1966 - 1974
  • [8] Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality
    Hong, MK
    Mehran, R
    Dangas, G
    Mintz, GS
    Lansky, AJ
    Pichard, AD
    Kent, KM
    Satler, LF
    Stone, GW
    Leon, MB
    [J]. CIRCULATION, 1999, 100 (24) : 2400 - 2405
  • [9] Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results
    Hong, MK
    Mehran, R
    Dangas, G
    Mintz, GS
    Lansky, A
    Kent, KM
    Pichard, AD
    Satler, LF
    Stone, GW
    Leon, MB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (01) : 150 - 154
  • [10] Lansky A, 1999, TXB INTERVENTIONAL C, P725